"
Team:BostonU/MoCloChara
From 2013.igem.org
| (3 intermediate revisions not shown) | |||
| Line 13: | Line 13: | ||
<br> | <br> | ||
<h5>MoClo Overview</h5><ul> | <h5>MoClo Overview</h5><ul> | ||
| - | <h7><p>The MoClo system allows directional assembly of DNA parts through using BsaI and BbsI (also called BpiI), two Type IIS restriction enzymes that leave 4bp overhangs after they cut DNA. These four base pair overhangs, or fusion sites, created by either enzyme can be any 4 bases and thus fusion sites can be user-defined. The fusion sites are used to enable directional assembly of DNA Parts. By defining non-palindromic fusion sites that flank each DNA Part, we can ensure proper order of assembly by assigning the same fusion sites between the 3’ and 5’ ends of two DNA Parts that are meant to go next to one another (Fig. 1).</p | + | <h7><p>The MoClo system allows directional assembly of DNA parts through using BsaI and BbsI (also called BpiI), two Type IIS restriction enzymes that leave 4bp overhangs after they cut DNA. These four base pair overhangs, or fusion sites, created by either enzyme can be any 4 bases and thus fusion sites can be user-defined. The fusion sites are used to enable directional assembly of DNA Parts. By defining non-palindromic fusion sites that flank each DNA Part, we can ensure proper order of assembly by assigning the same fusion sites between the 3’ and 5’ ends of two DNA Parts that are meant to go next to one another (Fig. 1).</p> |
<p><center><img src="https://static.igem.org/mediawiki/2013/8/8f/MoClo_order.png" width="400px"></a></p></h7> | <p><center><img src="https://static.igem.org/mediawiki/2013/8/8f/MoClo_order.png" width="400px"></a></p></h7> | ||
| Line 19: | Line 19: | ||
<h3><b>Figure 1:</b> Directional Assembly of DNA Parts. Two basic DNA Parts (DNA Part 1 and 2) are each shown in green vectors to denote the chloramphenicol resistance cassette and each has two 4bp non-palindromic fusion sites flanking the DNA Part. The third vector is the Destination Vector for the final construct, which is orange to denote the kanamycin resistance cassette and contains the alpha fragment of <i>lacZ</i> for blue-white screening. The BsaI sites (red text) are shown in the DNA Part vectors and Destination Vector with the direction they cut (red arrow).</h3> | <h3><b>Figure 1:</b> Directional Assembly of DNA Parts. Two basic DNA Parts (DNA Part 1 and 2) are each shown in green vectors to denote the chloramphenicol resistance cassette and each has two 4bp non-palindromic fusion sites flanking the DNA Part. The third vector is the Destination Vector for the final construct, which is orange to denote the kanamycin resistance cassette and contains the alpha fragment of <i>lacZ</i> for blue-white screening. The BsaI sites (red text) are shown in the DNA Part vectors and Destination Vector with the direction they cut (red arrow).</h3> | ||
<br> | <br> | ||
| + | </ul> | ||
<h5> MoClo Destination Vectors</h5><ul> | <h5> MoClo Destination Vectors</h5><ul> | ||
| Line 24: | Line 25: | ||
<p> The MoClo system we're using has three levels of assembly where basic parts (Level 0) are linked together to form transcriptional units (Level 1), which are then linked together to form functional genetic circuits (Level 2). Each MoClo Level also requires Destination Vectors which act as the end carrier for the inserted DNA part(s). In our assembly, we utilize blue/white screening for each level along with different antibiotic resistance markers as a secondary selection method for screening our clones.</p> | <p> The MoClo system we're using has three levels of assembly where basic parts (Level 0) are linked together to form transcriptional units (Level 1), which are then linked together to form functional genetic circuits (Level 2). Each MoClo Level also requires Destination Vectors which act as the end carrier for the inserted DNA part(s). In our assembly, we utilize blue/white screening for each level along with different antibiotic resistance markers as a secondary selection method for screening our clones.</p> | ||
| - | <p>We have converted the common BioBrick vectors pSB1C3, pSB1K3, and pSB1A2 into our MoClo Destination Vectors by inserting the alpha fragment of <i>lacZ</i> with flanking MoClo restriction and fusion sites into the cloning site (Fig. 2).</p | + | <p>We have converted the common BioBrick vectors pSB1C3, pSB1K3, and pSB1A2 into our MoClo Destination Vectors by inserting the alpha fragment of <i>lacZ</i> with flanking MoClo restriction and fusion sites into the cloning site (Fig. 2).</p> |
<br> | <br> | ||
<p><center><img src="https://static.igem.org/mediawiki/2013/9/98/MoClo_DV.png" width="600px"></a></p></h7> | <p><center><img src="https://static.igem.org/mediawiki/2013/9/98/MoClo_DV.png" width="600px"></a></p></h7> | ||
| Line 30: | Line 31: | ||
<h3><b>Figure 2:</b> Destination Vector Detail for MoClo Levels 0-2. The BsaI (in red) and BpiI (in purple) sites are interchanged between levels. The green backbone in Level 0 denotes chloramphenicol resistance, the orange for Level 1 is kanamycin, and the blue for Level 2 is ampicillin. The alpha <i>lacZ</i> fragment is in the cloning site for each level and the 4 blue N’s denote the fusion sites, to be designed by the user.</h3> | <h3><b>Figure 2:</b> Destination Vector Detail for MoClo Levels 0-2. The BsaI (in red) and BpiI (in purple) sites are interchanged between levels. The green backbone in Level 0 denotes chloramphenicol resistance, the orange for Level 1 is kanamycin, and the blue for Level 2 is ampicillin. The alpha <i>lacZ</i> fragment is in the cloning site for each level and the 4 blue N’s denote the fusion sites, to be designed by the user.</h3> | ||
<br> | <br> | ||
| - | + | </ul> | |
| Line 37: | Line 38: | ||
<p>As mentioned above, our MoClo system has three levels of assembly.<p> | <p>As mentioned above, our MoClo system has three levels of assembly.<p> | ||
| - | <p>Level 0: Basic DNA Parts (ex: promoter, gene, etc.) are PCR amplified and cloned into MoClo destination vectors to form Level 0 Parts. During the PCR reaction, the correct fusion sites and BpiI sites are added to either side of the DNA sequence. The orientation of the BpiI sites is crucial, where the 3’ BpiI site is inverted while the 5’ BpiI site is not (Fig. 3). This PCR reaction is mixed with its matching Destination Vector in a MoClo reaction. After a transformed clone has been confirmed, this plasmid is now called a Level 0 Part and has the following order of DNA sequences: BsaI site-Fusion site 1-DNA Part-Fusion site 2-BsaI inverted (Fig. 3). Notice that BpiI is removed from the final product, thus requiring the Destination Vector to contain both BpiI and BsaI flanking the fusion sites (Fig. 3).</p><br | + | <p>Level 0: Basic DNA Parts (ex: promoter, gene, etc.) are PCR amplified and cloned into MoClo destination vectors to form Level 0 Parts. During the PCR reaction, the correct fusion sites and BpiI sites are added to either side of the DNA sequence. The orientation of the BpiI sites is crucial, where the 3’ BpiI site is inverted while the 5’ BpiI site is not (Fig. 3). This PCR reaction is mixed with its matching Destination Vector in a MoClo reaction. After a transformed clone has been confirmed, this plasmid is now called a Level 0 Part and has the following order of DNA sequences: BsaI site-Fusion site 1-DNA Part-Fusion site 2-BsaI inverted (Fig. 3). Notice that BpiI is removed from the final product, thus requiring the Destination Vector to contain both BpiI and BsaI flanking the fusion sites (Fig. 3).</p><br> |
<p><center><img src="https://static.igem.org/mediawiki/2013/3/38/MoClo_L0PCR.png" width="550px"></a></p></h7> | <p><center><img src="https://static.igem.org/mediawiki/2013/3/38/MoClo_L0PCR.png" width="550px"></a></p></h7> | ||
| Line 45: | Line 46: | ||
<div id="Level1"> | <div id="Level1"> | ||
<br> | <br> | ||
| - | <h7 | + | <h7> |
<p>Level 1: Up to six Level 0 Parts are ligated together to form Level 1 Parts. In our lab, Level 1 Parts most often result in complete transcriptional units (ex: promoter-RBS-gene-terminator). Level 1 Parts are flanked by BpiI sites and two different 4pb-fusion sites (Fig. 4). | <p>Level 1: Up to six Level 0 Parts are ligated together to form Level 1 Parts. In our lab, Level 1 Parts most often result in complete transcriptional units (ex: promoter-RBS-gene-terminator). Level 1 Parts are flanked by BpiI sites and two different 4pb-fusion sites (Fig. 4). | ||
| - | </p><br | + | </p><br> |
<p><center><img src="https://static.igem.org/mediawiki/2013/3/37/MoClo_L1rxn.png" width="600px"></a></p></h7> | <p><center><img src="https://static.igem.org/mediawiki/2013/3/37/MoClo_L1rxn.png" width="600px"></a></p></h7> | ||
| Line 54: | Line 55: | ||
<div id="Level2"> | <div id="Level2"> | ||
| - | <br | + | <br> |
<h7> | <h7> | ||
<p>Level 2: Up to six Level 1 Parts are ligated together to form Level 2 Parts. More complex circuits, such as an inverter or NOR gate, can be built using Level 2 Parts. Like Level 0 Parts, Level 2 Parts are flanked by BsaI sites and two different 4pb-fusion sites. | <p>Level 2: Up to six Level 1 Parts are ligated together to form Level 2 Parts. More complex circuits, such as an inverter or NOR gate, can be built using Level 2 Parts. Like Level 0 Parts, Level 2 Parts are flanked by BsaI sites and two different 4pb-fusion sites. | ||
Latest revision as of 02:56, 28 September 2013
Modular Cloning DNA Assembly
An Introduction to MoClo
Modular Cloning, or MoClo, is a relatively new assembly method introduced in 2011 by Ernst Weber et al., whereby using Type IIS restriction sites allows the user to ligate up to six DNA parts together in a one-pot reaction. It is a method based on Golden Gate Assembly. Type IIS restriction enzymes cleave outside of their recognition site to one side, thus allowing for removal of those restriction sites when used properly. This helps eliminate excess base pairs, or scars, from forming between DNA Parts. However, in order to ligate together properly, MoClo utilizes a set of 4-base pair fusion sites, which remain behind after ligation and thus generate 4-base pair scars between DNA parts in the final DNA sequence following ligation of two or more parts.
MoClo Overview
The MoClo system allows directional assembly of DNA parts through using BsaI and BbsI (also called BpiI), two Type IIS restriction enzymes that leave 4bp overhangs after they cut DNA. These four base pair overhangs, or fusion sites, created by either enzyme can be any 4 bases and thus fusion sites can be user-defined. The fusion sites are used to enable directional assembly of DNA Parts. By defining non-palindromic fusion sites that flank each DNA Part, we can ensure proper order of assembly by assigning the same fusion sites between the 3’ and 5’ ends of two DNA Parts that are meant to go next to one another (Fig. 1).
Figure 1: Directional Assembly of DNA Parts. Two basic DNA Parts (DNA Part 1 and 2) are each shown in green vectors to denote the chloramphenicol resistance cassette and each has two 4bp non-palindromic fusion sites flanking the DNA Part. The third vector is the Destination Vector for the final construct, which is orange to denote the kanamycin resistance cassette and contains the alpha fragment of lacZ for blue-white screening. The BsaI sites (red text) are shown in the DNA Part vectors and Destination Vector with the direction they cut (red arrow).
MoClo Destination Vectors
The MoClo system we're using has three levels of assembly where basic parts (Level 0) are linked together to form transcriptional units (Level 1), which are then linked together to form functional genetic circuits (Level 2). Each MoClo Level also requires Destination Vectors which act as the end carrier for the inserted DNA part(s). In our assembly, we utilize blue/white screening for each level along with different antibiotic resistance markers as a secondary selection method for screening our clones.
We have converted the common BioBrick vectors pSB1C3, pSB1K3, and pSB1A2 into our MoClo Destination Vectors by inserting the alpha fragment of lacZ with flanking MoClo restriction and fusion sites into the cloning site (Fig. 2).
Figure 2: Destination Vector Detail for MoClo Levels 0-2. The BsaI (in red) and BpiI (in purple) sites are interchanged between levels. The green backbone in Level 0 denotes chloramphenicol resistance, the orange for Level 1 is kanamycin, and the blue for Level 2 is ampicillin. The alpha lacZ fragment is in the cloning site for each level and the 4 blue N’s denote the fusion sites, to be designed by the user.
MoClo Parts
As mentioned above, our MoClo system has three levels of assembly.
Level 0: Basic DNA Parts (ex: promoter, gene, etc.) are PCR amplified and cloned into MoClo destination vectors to form Level 0 Parts. During the PCR reaction, the correct fusion sites and BpiI sites are added to either side of the DNA sequence. The orientation of the BpiI sites is crucial, where the 3’ BpiI site is inverted while the 5’ BpiI site is not (Fig. 3). This PCR reaction is mixed with its matching Destination Vector in a MoClo reaction. After a transformed clone has been confirmed, this plasmid is now called a Level 0 Part and has the following order of DNA sequences: BsaI site-Fusion site 1-DNA Part-Fusion site 2-BsaI inverted (Fig. 3). Notice that BpiI is removed from the final product, thus requiring the Destination Vector to contain both BpiI and BsaI flanking the fusion sites (Fig. 3).
Figure 3: Construction of a Level 0 MoClo Part. PCR primers are designed as shown in the top of the figure to include 2bp (NN), then the 6bp BpiI site (in purple), 2bp (NN), then the 4-bp fusion site (in blue), followed by 18-24bp of the DNA part of interest. Once amplified with high fidelity DNA polymerase, the PCR product is mixed with the Level 0 Destination Vector that has matching fusion sites in a MoClo reaction to create the final Level 0 MoClo Part shown in the final plasmid.
Level 1: Up to six Level 0 Parts are ligated together to form Level 1 Parts. In our lab, Level 1 Parts most often result in complete transcriptional units (ex: promoter-RBS-gene-terminator). Level 1 Parts are flanked by BpiI sites and two different 4pb-fusion sites (Fig. 4).
Figure 4: Construction of a Level 1 MoClo Part. Four basic DNA Parts (promoter, RBS, CDS, and terminator) are each shown in green vectors to denote the chloramphenicol resistance cassette and each has two 4bp non-palindromic fusion sites flanking the DNA Part. The fifth vector is the Destination Vector for the final construct, which is orange to denote the kanamycin resistance cassette and contains lacZ for blue-white screening. The BsaI sites (red text) are shown in the DNA Part vectors and Destination Vector with the direction they cut (red arrow). The 4bp fusion sites (blue text) shown in the five top plasmids indicate the fusion sites that will remain with either the DNA Parts or the Destination Vector after the BsaI digestion.
Level 2: Up to six Level 1 Parts are ligated together to form Level 2 Parts. More complex circuits, such as an inverter or NOR gate, can be built using Level 2 Parts. Like Level 0 Parts, Level 2 Parts are flanked by BsaI sites and two different 4pb-fusion sites.
